Sugi Predict

Sugi Predict / Compounds / SCHEMBL27908

SCHEMBL27908

SCHEMBL27908

N#Cc1cc(C#N)cc(B(O)O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 7/20 0.61
▸ TTR P02766 2/20 0.41
▸ ALB P02768 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ P4HB P07237 1/20 0.36
▸ CA6 P23280 2/20 0.35
▸ CA14 Q9ULX7 2/20 0.35
▸ CA12 O43570 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CA3 P07451 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ GPR35 Q9HC97 2/20 0.33
▸ VCAM1 P19320 2/20 0.33
▸ TSHR P16473 1/20 0.32
▸ CA4 P22748 1/20 0.32
▸ CA5A P35218 1/20 0.32
▸ CA7 P43166 1/20 0.32
▸ CA5B Q9Y2D0 1/20 0.32
▸ MMP3 P08254 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15602898 0.95 ENPP2 (0.61) ENPP2TTRALBMEN1KMT2A
1,3-Propanediol SCHEMBL29185453 0.87 ENPP2 (0.50) ENPP2TTRALBMEN1KMT2A
SCHEMBL29952148 0.86 ENPP2 (0.53) ENPP2TTRALBMEN1KMT2A
SCHEMBL29954891 0.85 ENPP2 (0.48) ENPP2TTRALBMEN1KMT2A
SCHEMBL3326314 0.84 ENPP2 (0.52) ENPP2TTRALBMEN1KMT2A
SCHEMBL2377148 0.84 ENPP2 (0.52) ENPP2TTRALBMEN1KMT2A
SCHEMBL16516876 0.84 ENPP2 (0.52) ENPP2TTRALBMEN1KMT2A
SCHEMBL874242 0.84 ENPP2 (0.52) ENPP2
SCHEMBL16398417 0.84 ENPP2 (0.52) ENPP2TTRALBMEN1KMT2A
SCHEMBL18560100 0.84 ENPP2 (0.52) ENPP2TTRALBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118555852-A Self-assembled monolayer film for QLED, preparation method thereof and blue light QLED 南京信息工程大学 2024-08-27 — — CN claimed
WO-2025135309-A1 ORGANIC LIGHT-EMITTING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME 솔루스첨단소재 주식회사 2025-06-26 — — WO disclosed
EP-4222155-B1 MONONUCLEAR TRIPODAL HEXADENTATE IRIDIUM COMPLEXES FOR USE IN OLEDS UDC IRELAND LTD (IE) 2025-06-11 — — EP disclosed
CN-118555852-A Self-assembled monolayer film for QLED, preparation method thereof and blue light QLED 南京信息工程大学 2024-08-27 — — CN disclosed
WO-2024167154-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME (주)피엔에이치테크 2024-08-15 — — WO disclosed
CN-112390784-B Organic compound, organic light emitting diode including the same, and organic light emitting display device 乐金显示有限公司 2024-02-20 — — CN disclosed
CN-117497840-A Gel electrolyte, preparation method thereof and sodium ion battery 广东省豪鹏新能源科技有限公司 2024-02-02 — — CN disclosed
US-11889754-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same LG DISPLAY CO., LTD (KR) 2024-01-30 — — US disclosed
US-20230331754-A1 MONONUCLEAR TRIPODAL HEXADENTATE IRIDIUM COMPLEXES FOR USE IN OLEDS UDC IRELAND LIMITED (IE) 2023-10-19 — — US disclosed
US-20230329101-A1 Organic Light Emitting Compound And Organic Light Emitting Device Including Same P&h Tech Co., Ltd. (KR) 2023-10-12 — — US disclosed
WO-2012095143-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-07-19 — — WO disclosed
EP-2406240-A2 INHIBITORS OF BETA-SECRETASE Vitae Pharmaceuticals, Inc. (US) 2012-01-18 — — EP disclosed
US-20110218192-A1 Inhibitors Of Beta-Secretase VITAE PHARMACEUTICALS, INC. (US) 2011-09-08 — — US disclosed
US-20110218192-A1 Inhibitors Of Beta-Secretase VITAE PHARMACEUTICALS, INC. (US) 2011-09-08 — — US disclosed
WO-2011075747-A1 THERAPEUTIC COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-06-23 — — WO disclosed
EP-2324032-A2 INHIBITORS OF BETA-SECRETASE Vitae Pharmaceuticals, Inc. (US) 2011-05-25 — — EP disclosed
US-20110071126-A1 INHIBITORS OF BETA-SECRETASE VITAE PHARMACEUTICALS, INC. 2011-03-24 — — US disclosed
WO-2010105179-A2 INHIBITORS OF BETA-SECRETASE VITAE PHARMACEUTICALS, INC. (US) 2010-09-16 — — WO disclosed
WO-2010021680-A2 INHIBITORS OF BETA-SECRETASE VITAE PHARMACEUTICALS, INC. (US) 2010-02-25 — — WO disclosed
WO-2010021680-A2 INHIBITORS OF BETA-SECRETASE VITAE PHARMACEUTICALS, INC. (US) 2010-02-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110218192-A1 Inhibitors Of Beta-Secretase BACE1, BACE2, APP ENPP2 642/4885TTR 1344/4885ALB 4757/4885
US-20230331754-A1 MONONUCLEAR TRIPODAL HEXADENTATE IRIDIUM COMPLEXES FOR USE IN OLEDS OCIAD1, OCIAD2, NUDT1 ENPP2 163/4885TTR 3710/4885ALB 3433/4885
US-11889754-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same OCIAD1, OCIAD2, AOX1 ENPP2 2822/4885TTR 4104/4885ALB 3083/4885
US-20230329101-A1 Organic Light Emitting Compound And Organic Light Emitting Device Including Same ORMDL3, OR10J3, ORC3 ENPP2 3887/4885TTR 3793/4885ALB 3579/4885
US-20110071126-A1 INHIBITORS OF BETA-SECRETASE BACE1, BACE2, PSEN1 ENPP2 519/4885TTR 1160/4885ALB 4694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.